These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30695778)

  • 1. Impact of Different Pharmacotherapies on Long-Term Outcomes in Patients with Electrical Storm.
    Schupp T; Behnes M; Ellguth D; Müller J; Reiser L; Bollow A; Taton G; Reichelt T; Engelke N; Kim SH; Nienaber C; Akin M; Mashayekhi K; Bertsch T; Borggrefe M; Akin I
    Pharmacology; 2019; 103(3-4):179-188. PubMed ID: 30695778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter-Defibrillator Therapies.
    Schupp T; Behnes M; Weiß C; Nienaber C; Lang S; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Bertsch T; Akin M; Mashayekhi K; Borggrefe M; Akin I
    J Cardiovasc Pharmacol; 2019 May; 73(5):272-281. PubMed ID: 30747784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of recurrences in patients with electrical storm.
    Müller J; Behnes M; Ellguth D; Schupp T; Mashayekhi K; Borggrefe M; Akin I
    Scand Cardiovasc J; 2019 Apr; 53(2):71-76. PubMed ID: 30958708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia.
    Schupp T; Behnes M; Weiß C; Nienaber C; Lang S; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Ansari U; El-Battrawy I; Bertsch T; Akin M; Mashayekhi K; Borggrefe M; Akin I
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):353-363. PubMed ID: 30074111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
    Lai HM; Aronow WS; Kruger A; Desai H; Amin H; Frishman WH; Cohen M; Sorbera C
    Am J Cardiol; 2008 Jul; 102(1):77-8. PubMed ID: 18572039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 Oct; 289():109-117. PubMed ID: 31491742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of left ventricular ejection fraction in patients with electrical storm.
    Müller J; Behnes M; Ellguth D; Schupp T; Taton G; Reiser L; Reichelt T; Bollow A; Kim SH; Barth C; Saleh A; Rusnak J; Weidner K; Nienaber CA; Mashayekhi K; Akin M; Bertsch T; Weiß C; Borggrefe M; Akin I
    J Interv Card Electrophysiol; 2019 Sep; 55(3):307-315. PubMed ID: 30762187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Atrial Fibrillation in Electrical Storm.
    Müller J; Behnes M; Ellguth D; Schupp T; Taton G; Reiser L; Engelke N; Reichelt T; Bollow A; Kim SH; Barth C; Rusnak J; Weidner K; Mashayekhi K; Akin M; Bertsch T; Weiß C; Borggrefe M; Akin I
    Cardiology; 2019; 144(1-2):9-17. PubMed ID: 31527375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker.
    Hara M; Sakata Y; Nakatani D; Suna S; Usami M; Matsumoto S; Sugitani T; Nishino M; Sato H; Kitamura T; Nanto S; Hamasaki T; Hori M; Komuro I;
    Am J Cardiol; 2014 Jul; 114(1):1-8. PubMed ID: 24819900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure.
    Sorbets E; Labreuche J; Simon T; Delorme L; Danchin N; Amarenco P; Goto S; Meune C; Eagle KA; Bhatt DL; Steg PG
    Eur Heart J; 2014 Jul; 35(26):1760-8. PubMed ID: 24616336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
    Ermis C; Zadeii G; Zhu AX; Fabian W; Collins J; Lurie KG; Sakaguchi S; Benditt DG
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):578-83. PubMed ID: 12875416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias.
    Schupp T; Behnes M; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Ansari U; El-Battrawy I; Bertsch T; Weiß C; Nienaber C; Lang S; Akin M; Mashayekhi K; Borggrefe M; Akin I
    Int J Cardiol; 2019 Feb; 277():118-124. PubMed ID: 30473333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM; Callas PW; Bertges DJ;
    J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.
    Erlandson KM; Kitch D; Wester CW; Kalayjian RC; Overton ET; Castillo-Mancilla J; Koletar SL; Benson CA; Campbell TB; Robertson K; Lok JJ
    Clin Infect Dis; 2017 Nov; 65(12):2042-2049. PubMed ID: 29020174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.
    Galindo-Ocaña J; Bernabeu-Wittel M; Formiga F; Fuertes-Martín A; Barón-Franco B; Murcia-Zaragoza JM; Moreno-Gaviño L; Ollero-Baturone M;
    Eur J Intern Med; 2012 Mar; 23(2):179-84. PubMed ID: 22284251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.